According to the analysis conducted by Market Research Future (MRFR), the Global Genetic Testing Market is projected to thrive at a CAGR of 11.50% and is expected to acquire a market value of USD 22,834.19 Million by 2024.
Genetic testing is used in prenatal screening, diagnostics, and as a predictive tool. The testing market is predicted to propel due to the on-going development in the field to produce useful testing kits. Overall, the market is likely to experience significant expansion due to its growing requirement, rising acquisitions, and partnerships among key players.
The outbreak of COVID-19 has severely impacted the market. The worldwide lockdown to follow social distancing resulted in various challenges in the genetic testing market. COVID-19 resulted in the shutdown of testing labs and clinics, which has restricted face-to-face genetic counseling that is likely to impact the market negatively.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2009
Market Dynamics
The growing demand for genetic testing in oncology and the rising adoption of genetic tests into clinical care is predicted to propel the global genetic testing market during the projection tenure. The surging need for personalized medicine is another salient cause that can augment the genetic testing market size.
However, concerns regarding the standardization of genetic testing-based diagnostics and strict rules implemented for product approvals are expected to obstruct the market growth during the assessment period.
Drivers
Rising Prevalence of Genetic Disorders
The rising awareness about the benefits of genetic testing and the increasing prevalence of genetic disorders are primary drivers for the growth of the market. The increasing need to find a cure to cancer is expected to create a demand for effective testing that can augment the global cancer testing market. Additionally, the rapid expansion of the biotechnology sector are expected to propel the market significantly in the assessment period.
Opportunities
Integration of AI in Testing Procedures
The integration of AI and other smart technologies in genetic testing is expected to offer various market expansion opportunities during the forecast period. Besides, the innovation in product design and strong distribution partnerships are other factors that can provide lucrative chances to grow the trade.
Restraints
Lack of Expertise to Hinder the Market Growth
Despite the presence of various lucrative opportunities that can grow the market, the shortage of trained technicians is a significant factor that can hinder the market in emerging economies.
Challenges
Lack of Medical Solutions for all the Diseases Diagnosed
The biggest challenge for the genetics market is the lack of solutions for all the diseases diagnosed. However, funded research in prognosis post the detection can counter the challenge mentioned above.
Cumulative Growth Analysis
The market is expected to expand rapidly during the forecast period due to the rising awareness of genetic disorders. The industry is anticipated to witness various opportunities for expansion in the coming period.
Market Segmentation
By Type
Prescribed Genetic Testing Segment to Hold Maximum Market Share
Based on type, the global genetic testing market has been segmented into direct to consumer genetic testing and prescribed genetic testing. Among all genetic testing market segments, the prescribed genetic testing market is anticipated to expand at the highest CAGR while acquiring the USD 21653.91 million market value by 2024.
By Method
Molecular Genetic Test/DNA Tests to Hold the Maximum Market Share
Based on the method, the global market has been segmented into chromosomal genetic tests, molecular genetic tests/ DNA tests, and biochemical, genetic tests. Among all, the molecular genetic/DNA tests is expected to lead the global market while thriving at a CAGR of 11.78% during the forecast period.
By Application
Reproductive Health Segment to Acquire the Largest Market Share
Based on application, the global market has been segmented into cancer screening, reproductive health, ancestry, predictive and pre-symptomatic testing, and others. Among all, the reproductive health segment is expected to dominate the market.
Regional Analysis
The Americas to Dominate the Market Owing to the Increasing Incidences of Genetic Disorders
The Americas is expected to dominate the market for genetic testing due to the growing incidences of a genetic disorder and increasing demand for personalized genetic testing. The growing government support and the presence of the advanced healthcare sector is expected to boost the regional market during the forecast period.
APAC is expected to be the fastest-growing market due to the expanding patient pool and untapped market opportunities in the evolving countries. Besides, the growing initiatives to develop healthcare infrastructure to meet the demand for the rising geriatric population can further propel the regional market during the review tenure.
The European market for genetic testing is projected to be the second-largest during the forecast period. Recent developments and advances in molecular medicines in Europe are critical factors for the growth of this market. The increasing prevalence of genetic diseases and disorders has expanded the scope for the development of different genetic tests.
MEA is expected to grow due to the aging population, a rise in the number of chronic diseases such as cancer, and innovations in genetic testing.
Competitive Landscape
Product Innovation in Genetic Testing Platforms to Grow Competition among the Key Players
The market for genetic testing is highly competitive and comprises several established players. The on-going innovation and technical development in genetic testing platforms by various renowned players are likely to enhance the competitiveness of the market.
Industry News
November 2020: Taysha Gene Therapies, a US-based company, and Invitae, another US-based health startup, have announced a partnership to support Invitae’s Detect Lysosomal Storage Diseases ( Detect LSDs) and Behind the Seizure programs by offering free genetic testing to patients.
Behind the Seizure is a cross-company collaboration among the companies of the US and Canada, which is designed to increase access to genetic testing for children who experience seizures during their childhood.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/genetic-testing-market-2009
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
Mitochondrial Myopathy Diagnosis & Treatment Market Overview:In Mitochondrial myopathy, the mitochondria are affected which leads to symptoms such as muscle weakness, muscle cramping, low immunity, poor balance, and fatigue.
As per the analysis of Market Research Future (MRFR), The Global Mitochondrial Myopathy Diagnosis & Treatment Market is growing at a healthy pace and is expected to be USD 20.4 million in 2016, at a CAGR of 9.8% during the forecast period 2017-2025.The growth in the global mitochondrial myopathy diagnosis & treatment market can be attributed to various factors.
Besides, the rare nature of the disease and high cost of drug development along with high investment risk remain major challenges to the growth of the market.
Nevertheless, faster market uptake and low marketing cost are likely to present growth opportunities to the global mitochondrial myopathy diagnosis & treatment market.Mitochondrial Myopathy Diagnosis & Treatment Market SegmentationThe global mitochondrial myopathy diagnosis & treatment market has been segmented based on type, diagnostic tests, and therapy.By type, the global mitochondrial myopathy diagnosis & treatment market has been segmented into neuropathy, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), progressive external ophthalmoplegia (PEO), Pearson syndrome, Leigh syndrome, ataxia, mitochondrial DNA depletion syndrome (MDS), Retinitis pigmentosa (NARP), Kearns–Sayre syndrome (KSS), myoclonic epilepsy with ragged red fibres (MERRF), mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE).
The MELAS is the largest segment and is foreseen to capture a CAGR of 19.39% during 2017-2020.By diagnostic test, the global mitochondrial myopathy diagnosis & treatment market has been segmented into genetic tests, muscle biopsy, and biochemical test.
The genetic tests segment was the largest segment in 2016 and is projected to grow at a CAGR of 10.11% over the forecast period.By therapy, the global mitochondrial myopathy diagnosis & treatment market has been segmented into supportive therapy and targeted therapy.
major affective disorder treatment up to and through the 1960s, if any, was sometimes comprised of either protection the patient away or feat him or her to support him or herself.
These medications facilitate to stop or ease frenzied episodes.
These are shown to possess a good impact on mood.
Mood stabilizers area unit sometimes tried 1st, as a result of antidepressants will trigger frenzied episodes or rapid-cycling.
If Associate in Nursing medicament should be used, their area unit bound ones that area unit less possible to cause these issues.
The treatment of psychotic symptoms has evolved quickly in times.
Have you ever wondered why the same kind of lifestyle causes different effects on the health of 2 different individuals, even in case of identical twins?DNA is the answer to this difference.
You’re as unique as your DNA profileEvery information that makes you, you is encrypted in your DNA.
Your DNA profile can give your insights about the various tendencies of your body and guide you towards a lifestyle that’s unique to you, and can be your secret to a happy and healthy life.
Your health is the product of your genetics and your lifestyleYou can easily steer your body towards good health by altering your lifestyle (including food and exercise) by understanding your genetics/DNA profile.
Understand the correlation and personalize your lifestyle according to what’s best for your bodyKnow your health risks early to make informed decisions about your preventive action - Understanding your genetic risks for various health conditions and its effect on your organ systems can empower you in taking timely preventive and curative actions in consultation with your doctor.
Learn about the best diet plan for you - Stop following internet dieting fads and follow a personalized diet plan that actually works for your body.
Rising number of cancer cases, growing incidence of infectious diseases, strong government funding for medical science and the increasing application of patient-specific treatments are key factors contributing to high CAGR of Molecular Diagnostics during the forecast period.Market Size – USD 7.28 Billion in 2018, Market Growth - CAGR of 8.2%, Market Trends – impressive growth in colorectal cancer molecular diagnostics marketThe report on the global Molecular Diagnostics Market published by Reports and Data provides an in-depth assessment of the Molecular Diagnostics market including recent technological and product advancements, market drivers, challenges, current and emerging trends, opportunities, threats, risks, strategic developments, and other key features.
The report comprises 100+ pages and covers comprehensive assessment of market size, market share, revenue contribution, revenue share, growth rate, industrial chain analysis, regional analysis, and top companies.
It also provides strategic recommendations to formulate investment strategies and provides insights for new entrants.Get a sample of the report @ https://reportsanddata.com/sample-enquiry-form/945The report provides an in-depth analysis of the key developments and innovations of the market such as research and development advancements, product launches, mergers & acquisitions, joint ventures, partnerships, government deals, and collaborations.
The report offers a comprehensive assessment of key players in the market along with their global position, financial standing, business expansion plans, production and manufacturing capacity, and strategic alliances.Key players in the market include Abbott, Roche Diagnostics, QIAGEN, Danaher, Hologic, Becton, Siemens Healthcare GmbH, Bio-Rad Laboratories, Dickinson and Co., CepheidFor a better understanding of the global Molecular Diagnostics market dynamics, a regional analysis of the market across key geographical areas is offered in the report.
The market is spread across key geographical regions such as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.
Each region is analysed on the basis of the market scenario in the major countries of the regions to provide a deeper understanding of the market.
